You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
No AccessJournal of UrologyAdult Urology1 Dec 2008

Holmium Laser Enucleation of the Prostate—Outcomes Independent of Prostate Size?

View All Author Information


Generally treatment decisions for benign prostatic hyperplasia are based on prostate size and surgeon experience. Prostates greater than 100 gm often require open surgery. However, less invasive options are available. Randomized, controlled trials have demonstrated that holmium laser enucleation of the prostate is a viable and effective treatment for benign prostatic hyperplasia. We examined the outcome of holmium laser enucleation of the prostate based on prostate size.

Materials and Methods:

We retrospectively reviewed the records of all patients in our institutional review board approved database who underwent holmium laser enucleation of the prostate from January 1999 to October 2006. Patients were divided into 3 cohorts based on preoperative transrectal ultrasound prostate measurements, including less than 75, 75 to 125 and more than 125 gm. Patients with prostate cancer were excluded from study. Demographic, laboratory, operative, preoperative and postoperative data were obtained.


As prostate size increased, so did prostate specific antigen, and the urinary retention and enucleation rates. Hospitalization, catheterization, preoperative and postoperative outcomes were similar among the groups. On linear regression the decrease in prostate specific antigen highly correlated with the amount of tissue removed (p <0.0001). The complication rate was similar among the treatment groups. All patients did equally well in terms of postoperative urinary function independent of prostate size.


Holmium laser enucleation of the prostate is a safe and effective minimally invasive treatment for benign prostatic hyperplasia. It improved patient prostate specific antigen, American Urological Association symptom score and maximum urinary flow rate independent of the amount of benign prostatic hyperplasia present. Our results demonstrate the advantage of holmium laser enucleation of the prostate to treat all prostates regardless of size with favorable and equivalent outcomes.


  • 1 : Natural history of benign prostatic hyperplasia. Urology2001; 58: 5. Google Scholar
  • 2 : National Ambulatory Medical Care Survey: 1991 Summary: Advance Data From Vital and Health Statistics, No. 230. Hyattsville, Maryland: National Center for Health Statistics1993. Google Scholar
  • 3 : Management of symptomatic BPH in the US: who is treated and how?. Eur Urol1999; 36: 7. Google Scholar
  • 4 AUA guideline on management of benign prostatic hyperplasia: (2003): Chapter 1: diagnosis and treatment recommendations. AUA Practice Guidelines Committee. J Urol2003; 170: 530. LinkGoogle Scholar
  • 5 : Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol2008; 180: 246. LinkGoogle Scholar
  • 6 : Factors affecting change in quality of life after prostatectomy for benign prostatic hypertrophy: the impact of surgical techniques. J Urol1996; 155: 191. LinkGoogle Scholar
  • 7 : BPH treatment: a paradigm shift. Eur Urol2006; 49: 939. Google Scholar
  • 8 : Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia. Urology1998; 51: 1. Google Scholar
  • 9 : Techniques and long term results of surgical procedures for BPH. Eur Urol2006; 49: 970. Google Scholar
  • 10 : Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy. J Urol2001; 165: 459. LinkGoogle Scholar
  • 11 : Holmium laser enucleation of prostate (HoLEP): the Methodist hospital experience with greater than 75 gram enucleations. J Urol2003; 170: 149. LinkGoogle Scholar
  • 12 : Holmium laser enucleation of the prostate for prostates of >125 mL. BJU Int2006; 97: 81. Google Scholar
  • 13 : Laparoscopic retropubic simple prostatectomy. J Urol2005; 173: 757. LinkGoogle Scholar
  • 14 : Extraperitoneal laparoscopic prostatectomy (adenomectomy) for obstructing benign prostatic hyperplasia: transvesical and transcapsular (Millin) techniques. J Endourol2005; 19: 491. Google Scholar
  • 15 : Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18 month follow up of a randomized trial. J Endourol2004; 18: 189. Google Scholar
  • 16 : Holmium laser enucleation of the prostate vs open prostatectomy for prostates >70g: 24-month follow up. Eur Urol2006; 50: 563. Google Scholar
  • 17 : Holmium laser enucleation of the prostate: comparison of outcomes according to prostate size in 97 Japanese patients. J Endourol2007; 21: 192. Google Scholar
  • 18 : Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size?. J Endourol2004; 18: 183. Google Scholar
  • 19 : A randomized trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams; results at 2 years. Eur Urol2006; 50: 569. Google Scholar
  • 20 : Holmium laser enucleation of the prostate: a size-independent new “gold standard”. Urology2005; 66: 108. Google Scholar
  • 21 : High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology2004; 64: 1155. Google Scholar
  • 22 : Evaluation of fluid absorption during holmium laser enucleation of prostate by breath ethanol technique. J Urol2006; 175: 537. LinkGoogle Scholar
  • 23 : Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol2004; 172: 1926. LinkGoogle Scholar